Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy
Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy
About this item
Full title
Author / Creator
Publisher
Tokyo: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer Japan
Subjects
More information
Scope and Contents
Contents
Loss of body weight is a common (and the most serious) sequela after gastrectomy. It impairs quality of life, increases various diseases including infection, and may affect long-term survival. Ghrelin, an intrinsic ligand of the growth hormone secretagogue receptor, was discovered in the stomach in 1999. In addition to growth hormone secretion, ghr...
Alternative Titles
Full title
Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1513047794
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1513047794
Other Identifiers
ISSN
1436-3291
E-ISSN
1436-3305
DOI
10.1007/s10120-013-0300-8
